LFM
RCUS icon

Lumina Fund Management’s Arcus Biosciences RCUS Stock Holding History

Lumina Fund Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,000
Closed -$214K – 37
2018
Q4 		$214K Hold
20,000
– – 0.14% 30
2018
Q3 		$279K Buy
20,000
+3,000
+18% +$38.3K 0.13% 31
2018
Q2 		$208K Buy
17,000
+14,450
+567% +$227K 0.02% 43
2018
Q1 		$39K Buy
+2,550
New +$42.5K ﹤0.01% 44

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Lumina Fund Management's RCUS Position: Q1 2019 in Review

Lumina Fund Management sold out of Arcus Biosciences (RCUS) in Q1 2019, closing a stake of 20,000 shares — an estimated $214K sold.

Lumina Fund Management first reported a position in RCUS in Q1 2018 and held it in 4 quarters. The position peaked at $279K in Q3 2018. 64 funds tracked by Wall St. Rank hold RCUS as of Q1 2019.

  • Lumina Fund Management reported no remaining Arcus Biosciences position as of Q1 2019 after selling out during the quarter.
  • Lumina Fund Management sold 20,000 Arcus Biosciences shares in Q1 2019, an estimated $214K.
  • Lumina Fund Management first reported a position in Arcus Biosciences in Q1 2018 and held it in 4 quarters.
  • Lumina Fund Management's Arcus Biosciences position peaked at $279K in Q3 2018.
  • 64 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2019.

Based on Lumina Fund Management's 13F filing for Q1 2019, filed 15 May 2019.